Screening of serum alpha-fetoprotein (AFP) levels and ultrasonography every 6 months appear to identify only a few cases with early-stage HCC, and therefore, its use is not prescribed by several international authorities (7). The gene discussed is AFP; the disease is hepatocellular carcinoma.